What is the recommended maintenance protocol for NeuroStar transcranial magnetic stimulation (TMS) in patients with major depressive disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NeuroStar TMS Maintenance Treatment for Major Depressive Disorder

Based on current evidence, maintenance TMS should be delivered using either once-weekly or once-fortnightly sessions after achieving remission with acute treatment, with protocols continuing for at least 6-12 months to prevent relapse. 1, 2, 3

Acute Treatment Protocol First

Before considering maintenance, patients must complete an acute treatment course:

  • 20-30 daily sessions over 4-6 weeks 4
  • Peak efficacy occurs at 30,000-39,000 total pulses, 1,800-2,200 pulses per session, delivered over 14-16 sessions spanning 2.7-3.1 weeks 5
  • Both the Standard NeuroStar protocol (38 minutes/session) and the Dash protocol (18.75 minutes/session with shorter inter-train intervals) demonstrate equivalent efficacy with response rates of 58-72% and remission rates of 28-53% 6

Maintenance Treatment Protocols

Frequency Options

Two maintenance schedules show clinical effectiveness:

Once-Weekly Maintenance:

  • Most extensively studied approach 2, 3
  • Maintains remission in patients who achieved response during acute treatment
  • Statistically significant improvements in depression scores (standardized mean difference = 0.75) 1
  • Prevents relapse for 8-46 weeks in real-world settings 3

Once-Fortnightly Maintenance:

  • Emerging evidence supports this less intensive schedule 3
  • May be sufficient for stable patients in sustained remission
  • Requires closer monitoring initially to ensure adequacy

Duration of Maintenance

  • Minimum 6-12 months of maintenance treatment after achieving remission 2, 3
  • Some patients maintain remission for up to 8 years with ongoing maintenance 7
  • Duration should parallel antidepressant maintenance guidelines: 4-9 months for first episode, years to lifelong for recurrent depression 8

Protocol Selection Strategy

Rescue vs. Fixed Maintenance:

The evidence suggests rescue maintenance protocols (treatment delivered only when early warning signs emerge) may be more effective than fixed schedules (standardized mean difference = -1.17 vs -0.45), though this difference did not reach statistical significance 1.

Practical Algorithm:

  1. Start with once-weekly fixed maintenance for the first 3 months post-remission
  2. If stable remission maintained, consider transitioning to once-fortnightly sessions
  3. Implement rescue protocols (return to weekly or more frequent sessions) at first signs of symptom re-emergence
  4. Monitor with standardized scales (PHQ-9, HAM-D6, CGI-S) at each session 2, 3

Critical Monitoring Points

  • Assess depression severity at every maintenance session using validated scales
  • Watch for early warning signs: sleep disturbance, anhedonia, concentration difficulties
  • If HAM-D6 scores increase or partial remission develops, immediately increase frequency back to weekly or twice-weekly sessions 2
  • Patients can resume normal activities immediately after sessions, though driving immediately post-treatment is discouraged 4

Important Caveats

Significant heterogeneity exists in maintenance protocols across studies (I² = 90%), warranting caution in generalizing results 1. The lack of standardized consensus guidelines means protocols must be adapted based on:

  • Individual relapse history (patients with ≥2 prior episodes need longer maintenance) 8
  • Response stability during acute treatment
  • Concurrent medication status
  • Access to treatment (frequent visits remain a practical barrier) 9

The 2022 VA/DoD guidelines recommend rTMS for treatment-resistant depression (patients who failed ≥2 adequate medication trials) but note that one veteran-specific study found no difference from sham, possibly due to strong placebo effects from frequent clinical contact 9. This underscores the importance of proper patient selection and realistic expectation-setting.

Maintenance TMS represents a viable strategy for sustaining remission in MDD, with the strongest evidence supporting weekly sessions for 6-12 months, adjustable based on clinical response and relapse risk factors.

References

Research

Weekly transcranial magnetic stimulation (TMS) maintenance: a case series.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2024

Related Questions

Can Trintellix (vortioxetine) be co‑administered with mirtazapine?
How should I transition an elderly patient with depression from venlafaxine 150 mg daily to mirtazapine?
What are the pros and cons of first‑line pharmacologic treatments for moderate‑to‑severe depression in adults, including selective serotonin reuptake inhibitors (SSRIs), serotonin‑norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine?
How should treatment-resistant depression be managed when the patient has not improved on venlafaxine 150 mg daily?
For a 77-year-old male with anxiety and depression who is taking lamotrigine (Lamictal) 200 mg daily, mirtazapine (Remeron) 15 mg at bedtime, and duloxetine 30 mg in the morning and 60 mg at bedtime, should a low‑dose atypical antipsychotic be added to augment his regimen, and what dose and monitoring are recommended?
What antibiotic is recommended after incision and drainage of a labia majora abscess?
Which mood stabilizer is safest for a patient with premature ventricular contractions and no structural heart disease?
What concentration and treatment duration of erythromycin ophthalmic ointment is recommended for an adult with a hordeolum?
What mood stabilizers can be used safely in a patient with elevated liver function tests (high LFTs)?
How should an elevated levetiracetam (Keppra) level be managed in a patient?
What preventive measures and acute management should a young adult follow for respiratory infections such as influenza and COVID‑19?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.